|Articles|September 1, 2002

Effective Lipid Management: A Managed Care Perspective of Clinical Findings
Volume 8
Issue 12 Suppl

New Therapeutic Options in the National Cholesterol Education Program Adult Treatment Panel III

Author(s)Robert L. Talbert, PharmD

Download PDF: New Therapeutic Options in the National Cholesterol Education Program Adult Treatment Panel III

Articles in this issue

almost 24 years ago

Article

Participating Faculty

almost 24 years ago

Article

Effective Lipid Management: A Managed Care Perspective of Clinical Findings

almost 24 years ago

Article

Understanding Niacin Formulations

almost 24 years ago

Article

Niacin-Based Therapy for Dyslipidemia: Past Evidence and Future Advances

almost 24 years ago

Article

Delivering Effective Lipid Management in the Managed Care Setting

almost 24 years ago

Article

Continuing Education Quiz

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

New Therapeutic Options in the National Cholesterol Education Program Adult Treatment Panel III

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

AI Chatbots Score Below 28% on Colorectal Cancer Questions

5 Notable FDA Approvals From the First Half of 2026

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

New Therapeutic Options in the National Cholesterol Education Program Adult Treatment Panel III

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

AI Chatbots Score Below 28% on Colorectal Cancer Questions

5 Notable FDA Approvals From the First Half of 2026

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues